rafoxanide has been researched along with niclosamide in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barak, LS; Chen, M; Chen, W; Lu, J; Lyerly, HK; Mook, RA | 1 |
| Constant, P; Daffé, M; Guillet, V; Le, NH; Marrakchi, H; Maveyraud, L; Mourey, L; Nahoum, V; Tranier, S; Verhaeghe, P | 1 |
| Cifelli, S; Ewanciw, DV; Mickle, WG; Ostlind, DA; Smith, SK | 1 |
| AbdelKhalek, A; Abutaleb, NS; Mohammad, H; Seleem, MN | 1 |
| Berastegui-Cabrera, J; Marrugal-Lorenzo, JA; Pachón, J; Sánchez-Céspedes, J; Serna-Gallego, A | 1 |
5 other study(ies) available for rafoxanide and niclosamide
| Article | Year |
|---|---|
Small molecule modulators of Wnt/β-catenin signaling.
Topics: beta Catenin; Cell Line, Tumor; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Molecular Structure; Niclosamide; Small Molecule Libraries; Structure-Activity Relationship; Wnt Signaling Pathway | 2013 |
Drug screening approach against mycobacterial fatty acyl-AMP ligase FAAL32 renews the interest of the salicylanilide pharmacophore in the fight against tuberculosis.
Topics: Adenosine Monophosphate; Antitubercular Agents; Drug Evaluation, Preclinical; Humans; Mycobacterium tuberculosis; Salicylanilides; Tuberculosis | 2022 |
The Hymenolepis diminuta-golden hamster (Mesocricetus auratus) model for the evaluation of gastrointestinal anticestode activity.
Topics: Administration, Oral; Amidines; Animals; Anticestodal Agents; Cambendazole; Cricetinae; Digestive System; Disease Models, Animal; Hymenolepiasis; Hymenolepis; Insect Vectors; Intestine, Small; Ivermectin; Male; Mebendazole; Mesocricetus; Nicarbazin; Niclosamide; Praziquantel; Rafoxanide; Random Allocation; Tribolium | 2004 |
Repurposing niclosamide for intestinal decolonization of vancomycin-resistant enterococci.
Topics: Animals; Anti-Bacterial Agents; Depsipeptides; Drug Repositioning; Feces; Humans; Intestines; Linezolid; Mice; Microbial Sensitivity Tests; Niclosamide; Oxyclozanide; Rafoxanide; Salicylanilides; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2018 |
Repositioning salicylanilide anthelmintic drugs to treat adenovirus infections.
Topics: A549 Cells; Adenoviridae; Adenoviridae Infections; Antiviral Agents; Community-Acquired Infections; Drug Repositioning; HEK293 Cells; Humans; Niclosamide; Oxyclozanide; Rafoxanide | 2019 |